TTrialPathMatch Me to Trials
← Back to trials
RecruitingMigraineMigraine DiseaseMigraine Headache

Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals

Eligible age

18–60 yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Caffeine extracted from green tea to abort acute attack of Migraine

Sponsor: Ain Shams University

You may qualify if…

  • ✓ Patients suffering from migraine with aura, migraine without aura, episodic, and chronic migraine according to ICHD-3 diagnosis will be legible for the study.

You may not qualify if…

  • ✕ Patients who have history of any cardiac dysrhythmia, hypertension, ischemic heart disease, active peptic ulcer disease, inflammatory bowel disease, obsessive compulsive disorder, pregnancy, breast-feeding, renal failure, hepatic failure, sleep disorder, mental retardation, and history of substance abuse that prevent them from cooperating with us during the study Patients who had headache due to: Cluster headache, trigeminal neuralgia, glossopharyngeal neuralgia, headache secondary to trauma, cranial disorder, vascular disorder, infection, or mass lesion, will also be excluded

Source: ClinicalTrials.gov · NCT07022496 · last updated 2025-06-15

Assessment of Oral Caffeine Intake in Changing the Severity of Acute M · TrialPath